GLP-1 RAs are also contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, which requires clinical awareness [,]
Additionally, in the analyses of WL after surgery and before treatment, the intercepts were also positive for age with p-value = 0.07 and p-value = 0.09 for GLP-1RAs and placebo treatment groups, respectively, suggesting that older age may be associated with slightly reduced WL
Canada: As of now, Health Canada has not approved bremelanotide either
This means insulin doesnt help your body process sugar as it should
Their integrated 12-hour data followed the same direction
Understanding the distinction between research and pharmaceutical grade peptides helps researchers contextualize what they are purchasing and set appropriate expectations for quality, documentation, and regulatory status